6
|
Lowry MF, Lockman K, Herndon C, Atayee RS, Juba KM, Pawasauskas J, Phantumvanit V, Ray JB, Pruskowski J. Development and validation of a performance-based palliative care assessment tool for student pharmacists. CURRENTS IN PHARMACY TEACHING & LEARNING 2024; 16:39-48. [PMID: 38158329 DOI: 10.1016/j.cptl.2023.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/12/2023] [Revised: 09/28/2023] [Accepted: 12/17/2023] [Indexed: 01/03/2024]
Abstract
INTRODUCTION Integration of hospice and palliative care principles within pharmacy curricula is essential to fill the need of pharmacist training in this growing specialty. A formalized assessment tool to evaluate skill development does not exist for student pharmacists specific to palliative care. The objective of this study was to develop a valid and reliable, palliative care-focused, performance-based assessment tool for student pharmacists. METHODS Eight academic palliative care (PC) pharmacists were recruited for the workgroup to perform domain development, validation, tool creation, and reliability testing for this performance-based assessment tool. Hospice and palliative care clinical pharmacist entrustable professional activities (EPAs) served as the framework. Content validity testing utilized content validity index and scale universal agreement (S-CVI/UA) to determine level of agreement for activities included in the tool. Student volunteers completed a standardized patient case and workgroup members served as raters during the reliability testing phase. Interrater reliability was measured through calculation of Fleiss Kappa scores for each activity. RESULTS Out of 14 EPAs, nine were deemed "essential" to include in the tool. Thirty-four supporting activities for the nine essential EPAs were drafted. Two rounds of content validity testing were necessary to achieve S-CVI/UA of 0.9593. Consensus was reached from workgroup members for activities deemed necessary to include in the tool after questionnaire distribution utilizing a Fleiss Kappa cutoff >0.6. CONCLUSIONS This validated tool will afford colleges and schools of pharmacy with PC curricula an opportunity to assess student achievement of PC-specific skills and evaluate curricular effectiveness.
Collapse
Affiliation(s)
- Maria Felton Lowry
- University of Pittsburgh School of Pharmacy, Department of Pharmacy and Therapeutics, 3501 Terrace Street, Pittsburgh, PA 15213, United States; UPMC Palliative and Supportive Institute, Iroquois Building, Suite 308.15, 3600 Forbes Avenue at Meyran Ave, Pittsburgh, PA 15213, United States.
| | - Kashelle Lockman
- University of Iowa College of Pharmacy, 180 S Grand Ave, 336 CPB, Iowa City, IA 52242, United States.
| | - Christopher Herndon
- Southern Illinois University Edwardsville, 200 University Park Drive, Edwardsville, IL 62026, United States
| | - Rabia S Atayee
- University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego Health, Palliative Care Program, 9255 Pharmacy Lane, MC 0657, La Jolla, CA 92093, United States.
| | - Katherine M Juba
- St. John Fisher University, Wegmans School of Pharmacy, 3690 East Ave., Rochester, NY 15618, United States.
| | - Jayne Pawasauskas
- University of Rhode Island College of Pharmacy, 7 Greenhouse Rd, 295A Avedisian Hall, Kingston, RI 02881, United States.
| | - Victor Phantumvanit
- Clinical Pharmacy Specialist, Palliative Care, Dana-Faber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, United States.
| | - James B Ray
- University of Iowa College of Pharmacy, 180 S Grand Ave, 336 CPB, Iowa City, IA 52242, United States.
| | - Jennifer Pruskowski
- University of Pittsburgh School of Pharmacy, Department of Pharmacy and Therapeutics, 3501 Terrace Street, Pittsburgh, PA 15213, United States; Pittsburgh Geriatric Research Education and Clinical Center (GRECC), Pittsburgh Veterans Affairs, Healthcare System, Pittsburgh, PA, United States; University of Pittsburgh School of Medicine, Division of Geriatric Medicine, Kaufmann Medical Building, Suite 500, 3471 Fifth Avenue, Pittsburgh, PA 15213, United States.
| |
Collapse
|
8
|
Lockman K, Lowry MF, DiScala S, Lovell AG, Uritsky TJ, Kematick BS, Schmidt M, Wetshtein AM, Scullion B, Herndon CM, Atayee RS. Development of Entrustable Professional Activities for Specialist Hospice and Palliative Care Pharmacists. J Pain Symptom Manage 2022; 64:37-48. [PMID: 35304228 DOI: 10.1016/j.jpainsymman.2022.03.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/03/2021] [Revised: 03/03/2022] [Accepted: 03/08/2022] [Indexed: 12/30/2022]
Abstract
CONTEXT Entrustable professional activities (EPAs) translate competencies into explicit, practical terms that clearly state the expected roles and responsibilities of clinicians who have achieved proficiency and expertise in a field. EPAs are defined for Hospice and Palliative Medicine physicians but not for other members of Hospice and Palliative Care (HAPC) interprofessional teams, including pharmacists. OBJECTIVES The objective of this study was to develop EPAs for HAPC pharmacists. METHODS An 11-member workgroup of HAPC pharmacists was convened to develop candidate EPAs using nominal group and modified-Delphi methods. Content validity index was used as a measure of consensus, defined a priori at ≥ 60%. Vetting occurred via intra- and interprofessional stakeholder reactor groups and a national survey of HAPC pharmacists. RESULTS Following an iterative process of workgroup and stakeholder consensus-building, 15 HAPC pharmacist EPAs were developed. Among the workgroup, all 15 EPAs reached ≥ 70% consensus, indicating appropriate internal validity. In a national survey of 185 HAPC pharmacists with a 20% response rate, 13 EPAs were rated by most respondents as "essential" and 2 were rated by most respondents as "important but not essential." Respondents indicated the 15 EPA set represented the core professional activities of HAPC pharmacists well (median rating of 5 on a Likert-like scale, IQR 1). CONCLUSION Fifteen consensus EPAs describe essential activities of HAPC pharmacists in direct patient care, leadership, education, and scholarship. These EPAs will further guide pharmacist training programs, HAPC services seeking to incorporate a specialized pharmacist on the team, and currently practicing HAPC pharmacists.
Collapse
Affiliation(s)
- Kashelle Lockman
- University of Iowa College of Pharmacy (K.L.), Iowa City, Iowa, USA; University of Pittsburgh School of Pharmacy (M.F.L.), Pittsburgh, Pennsylvania, USA; West Palm Beach (WPB) Veterans Affairs Medical Center (S.D.), West Palm Beach, Florida, USA; Optum Hospice Pharmacy Services (A.G.L.), Westerville, Ohio, USA; Department of Pharmacy (T.J.U.), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Dana-Farber Cancer Institute (B.S.K.), Boston, Massachusetts, USA; University of Iowa College of Pharmacy (M.S.), Iowa City, Iowa, USA; Cleveland Clinic Fairview Hospital (A.M.W.), Cleveland, Ohio, USA; Dana-Farber Cancer Institute (B.S.), Boston, Massachusetts, USA; School of Pharmacy (C.M.H.), Southern Illinois University Edwardsville, Edwardsville, Illinois, USA; San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (R.S.A.), University of California, San Diego, California, USA; San Diego Health, Palliative Care Program (R.S.A.), University of California, San Diego, California, USA.
| | - Maria F Lowry
- University of Iowa College of Pharmacy (K.L.), Iowa City, Iowa, USA; University of Pittsburgh School of Pharmacy (M.F.L.), Pittsburgh, Pennsylvania, USA; West Palm Beach (WPB) Veterans Affairs Medical Center (S.D.), West Palm Beach, Florida, USA; Optum Hospice Pharmacy Services (A.G.L.), Westerville, Ohio, USA; Department of Pharmacy (T.J.U.), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Dana-Farber Cancer Institute (B.S.K.), Boston, Massachusetts, USA; University of Iowa College of Pharmacy (M.S.), Iowa City, Iowa, USA; Cleveland Clinic Fairview Hospital (A.M.W.), Cleveland, Ohio, USA; Dana-Farber Cancer Institute (B.S.), Boston, Massachusetts, USA; School of Pharmacy (C.M.H.), Southern Illinois University Edwardsville, Edwardsville, Illinois, USA; San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (R.S.A.), University of California, San Diego, California, USA; San Diego Health, Palliative Care Program (R.S.A.), University of California, San Diego, California, USA
| | - Sandra DiScala
- University of Iowa College of Pharmacy (K.L.), Iowa City, Iowa, USA; University of Pittsburgh School of Pharmacy (M.F.L.), Pittsburgh, Pennsylvania, USA; West Palm Beach (WPB) Veterans Affairs Medical Center (S.D.), West Palm Beach, Florida, USA; Optum Hospice Pharmacy Services (A.G.L.), Westerville, Ohio, USA; Department of Pharmacy (T.J.U.), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Dana-Farber Cancer Institute (B.S.K.), Boston, Massachusetts, USA; University of Iowa College of Pharmacy (M.S.), Iowa City, Iowa, USA; Cleveland Clinic Fairview Hospital (A.M.W.), Cleveland, Ohio, USA; Dana-Farber Cancer Institute (B.S.), Boston, Massachusetts, USA; School of Pharmacy (C.M.H.), Southern Illinois University Edwardsville, Edwardsville, Illinois, USA; San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (R.S.A.), University of California, San Diego, California, USA; San Diego Health, Palliative Care Program (R.S.A.), University of California, San Diego, California, USA
| | - Amanda G Lovell
- University of Iowa College of Pharmacy (K.L.), Iowa City, Iowa, USA; University of Pittsburgh School of Pharmacy (M.F.L.), Pittsburgh, Pennsylvania, USA; West Palm Beach (WPB) Veterans Affairs Medical Center (S.D.), West Palm Beach, Florida, USA; Optum Hospice Pharmacy Services (A.G.L.), Westerville, Ohio, USA; Department of Pharmacy (T.J.U.), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Dana-Farber Cancer Institute (B.S.K.), Boston, Massachusetts, USA; University of Iowa College of Pharmacy (M.S.), Iowa City, Iowa, USA; Cleveland Clinic Fairview Hospital (A.M.W.), Cleveland, Ohio, USA; Dana-Farber Cancer Institute (B.S.), Boston, Massachusetts, USA; School of Pharmacy (C.M.H.), Southern Illinois University Edwardsville, Edwardsville, Illinois, USA; San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (R.S.A.), University of California, San Diego, California, USA; San Diego Health, Palliative Care Program (R.S.A.), University of California, San Diego, California, USA
| | - Tanya J Uritsky
- University of Iowa College of Pharmacy (K.L.), Iowa City, Iowa, USA; University of Pittsburgh School of Pharmacy (M.F.L.), Pittsburgh, Pennsylvania, USA; West Palm Beach (WPB) Veterans Affairs Medical Center (S.D.), West Palm Beach, Florida, USA; Optum Hospice Pharmacy Services (A.G.L.), Westerville, Ohio, USA; Department of Pharmacy (T.J.U.), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Dana-Farber Cancer Institute (B.S.K.), Boston, Massachusetts, USA; University of Iowa College of Pharmacy (M.S.), Iowa City, Iowa, USA; Cleveland Clinic Fairview Hospital (A.M.W.), Cleveland, Ohio, USA; Dana-Farber Cancer Institute (B.S.), Boston, Massachusetts, USA; School of Pharmacy (C.M.H.), Southern Illinois University Edwardsville, Edwardsville, Illinois, USA; San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (R.S.A.), University of California, San Diego, California, USA; San Diego Health, Palliative Care Program (R.S.A.), University of California, San Diego, California, USA
| | - Benjamin S Kematick
- University of Iowa College of Pharmacy (K.L.), Iowa City, Iowa, USA; University of Pittsburgh School of Pharmacy (M.F.L.), Pittsburgh, Pennsylvania, USA; West Palm Beach (WPB) Veterans Affairs Medical Center (S.D.), West Palm Beach, Florida, USA; Optum Hospice Pharmacy Services (A.G.L.), Westerville, Ohio, USA; Department of Pharmacy (T.J.U.), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Dana-Farber Cancer Institute (B.S.K.), Boston, Massachusetts, USA; University of Iowa College of Pharmacy (M.S.), Iowa City, Iowa, USA; Cleveland Clinic Fairview Hospital (A.M.W.), Cleveland, Ohio, USA; Dana-Farber Cancer Institute (B.S.), Boston, Massachusetts, USA; School of Pharmacy (C.M.H.), Southern Illinois University Edwardsville, Edwardsville, Illinois, USA; San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (R.S.A.), University of California, San Diego, California, USA; San Diego Health, Palliative Care Program (R.S.A.), University of California, San Diego, California, USA
| | - Michelle Schmidt
- University of Iowa College of Pharmacy (K.L.), Iowa City, Iowa, USA; University of Pittsburgh School of Pharmacy (M.F.L.), Pittsburgh, Pennsylvania, USA; West Palm Beach (WPB) Veterans Affairs Medical Center (S.D.), West Palm Beach, Florida, USA; Optum Hospice Pharmacy Services (A.G.L.), Westerville, Ohio, USA; Department of Pharmacy (T.J.U.), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Dana-Farber Cancer Institute (B.S.K.), Boston, Massachusetts, USA; University of Iowa College of Pharmacy (M.S.), Iowa City, Iowa, USA; Cleveland Clinic Fairview Hospital (A.M.W.), Cleveland, Ohio, USA; Dana-Farber Cancer Institute (B.S.), Boston, Massachusetts, USA; School of Pharmacy (C.M.H.), Southern Illinois University Edwardsville, Edwardsville, Illinois, USA; San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (R.S.A.), University of California, San Diego, California, USA; San Diego Health, Palliative Care Program (R.S.A.), University of California, San Diego, California, USA
| | - Andrea M Wetshtein
- University of Iowa College of Pharmacy (K.L.), Iowa City, Iowa, USA; University of Pittsburgh School of Pharmacy (M.F.L.), Pittsburgh, Pennsylvania, USA; West Palm Beach (WPB) Veterans Affairs Medical Center (S.D.), West Palm Beach, Florida, USA; Optum Hospice Pharmacy Services (A.G.L.), Westerville, Ohio, USA; Department of Pharmacy (T.J.U.), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Dana-Farber Cancer Institute (B.S.K.), Boston, Massachusetts, USA; University of Iowa College of Pharmacy (M.S.), Iowa City, Iowa, USA; Cleveland Clinic Fairview Hospital (A.M.W.), Cleveland, Ohio, USA; Dana-Farber Cancer Institute (B.S.), Boston, Massachusetts, USA; School of Pharmacy (C.M.H.), Southern Illinois University Edwardsville, Edwardsville, Illinois, USA; San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (R.S.A.), University of California, San Diego, California, USA; San Diego Health, Palliative Care Program (R.S.A.), University of California, San Diego, California, USA
| | - Bridget Scullion
- University of Iowa College of Pharmacy (K.L.), Iowa City, Iowa, USA; University of Pittsburgh School of Pharmacy (M.F.L.), Pittsburgh, Pennsylvania, USA; West Palm Beach (WPB) Veterans Affairs Medical Center (S.D.), West Palm Beach, Florida, USA; Optum Hospice Pharmacy Services (A.G.L.), Westerville, Ohio, USA; Department of Pharmacy (T.J.U.), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Dana-Farber Cancer Institute (B.S.K.), Boston, Massachusetts, USA; University of Iowa College of Pharmacy (M.S.), Iowa City, Iowa, USA; Cleveland Clinic Fairview Hospital (A.M.W.), Cleveland, Ohio, USA; Dana-Farber Cancer Institute (B.S.), Boston, Massachusetts, USA; School of Pharmacy (C.M.H.), Southern Illinois University Edwardsville, Edwardsville, Illinois, USA; San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (R.S.A.), University of California, San Diego, California, USA; San Diego Health, Palliative Care Program (R.S.A.), University of California, San Diego, California, USA
| | - Christopher M Herndon
- University of Iowa College of Pharmacy (K.L.), Iowa City, Iowa, USA; University of Pittsburgh School of Pharmacy (M.F.L.), Pittsburgh, Pennsylvania, USA; West Palm Beach (WPB) Veterans Affairs Medical Center (S.D.), West Palm Beach, Florida, USA; Optum Hospice Pharmacy Services (A.G.L.), Westerville, Ohio, USA; Department of Pharmacy (T.J.U.), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Dana-Farber Cancer Institute (B.S.K.), Boston, Massachusetts, USA; University of Iowa College of Pharmacy (M.S.), Iowa City, Iowa, USA; Cleveland Clinic Fairview Hospital (A.M.W.), Cleveland, Ohio, USA; Dana-Farber Cancer Institute (B.S.), Boston, Massachusetts, USA; School of Pharmacy (C.M.H.), Southern Illinois University Edwardsville, Edwardsville, Illinois, USA; San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (R.S.A.), University of California, San Diego, California, USA; San Diego Health, Palliative Care Program (R.S.A.), University of California, San Diego, California, USA
| | - Rabia S Atayee
- University of Iowa College of Pharmacy (K.L.), Iowa City, Iowa, USA; University of Pittsburgh School of Pharmacy (M.F.L.), Pittsburgh, Pennsylvania, USA; West Palm Beach (WPB) Veterans Affairs Medical Center (S.D.), West Palm Beach, Florida, USA; Optum Hospice Pharmacy Services (A.G.L.), Westerville, Ohio, USA; Department of Pharmacy (T.J.U.), Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Dana-Farber Cancer Institute (B.S.K.), Boston, Massachusetts, USA; University of Iowa College of Pharmacy (M.S.), Iowa City, Iowa, USA; Cleveland Clinic Fairview Hospital (A.M.W.), Cleveland, Ohio, USA; Dana-Farber Cancer Institute (B.S.), Boston, Massachusetts, USA; School of Pharmacy (C.M.H.), Southern Illinois University Edwardsville, Edwardsville, Illinois, USA; San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences (R.S.A.), University of California, San Diego, California, USA; San Diego Health, Palliative Care Program (R.S.A.), University of California, San Diego, California, USA
| |
Collapse
|